Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Lyme disease is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Lyme disease is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. The 7 average consequence score is above the beat benchmark of 6.6 in the same window. VLA15 appears in 1 tracked Healthcare story from March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering VLA15. Shared-story counts are live from our verified record — not editorial picks.
Regulatory Submission
Anticipated filing for FDA and EMA approval based on final trial data.
Efficacy Milestone
Trial results indicate efficacy exceeding the 70% threshold.
Phase 3 Launch
The VALOR trial begins enrolling thousands of participants in endemic areas.
Partnership Formed
Pfizer and Valneva enter a collaboration agreement to develop VLA15.
Pfizer and Valneva have announced that their Lyme disease vaccine candidate, VLA15, demonstrated more than 70% efficacy in late-stage clinical trials. This breakthrough marks the first successful human vaccine development for the tick-borne illness in over two decades, addressing a critical gap in public health.
Source: ktbb.com · madrock1025.com
VLA15 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
